Sort
21,453 grants matching “tuberculosis”
Non-peptidic HIV vaccine
$500,000Miroslav Malkovsky · University Of Wisconsin-Madison · RC2 · FY2009 · CA
Monochromatic 222 nm UV light: Development of a safe, cost-effective technology for the efficient reduction of bacterial and viral infection and transmission
$500,000Sung-Jin Park · Eden Park Illumination, Inc. · R42 · FY2019 · AI
Optimizing Clinical Outcomes in HIV-infected Adults & Children using Xpert MTB/RI
$500,000Margaret Phiri Kasaro · Centre For Infectious Disease Research · U01 · FY2013 · GH
DAIDS and DTBE Partnership for TB and TB/HIV Research
$500,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2015 · AI
Targeting MDR-TB
$500,000Robert C Reynolds · Southern Research Institute · RC1 · FY2010 · AI
Linked; Building Capacity for Cardiovascular Research and Training in Uganda
$500,000Nelson K Sewankambo · Makerere University College Of Health Sciences · R24 · FY2010 · TW
Medical Education Partnership Initiative in Nigeria
$500,000David Olufemi Olaleye · College Of Medicine, University Of Ibadan · R24 · FY2012 · TW
Building Tuberculosis Clinical Research Capacity in China
$500,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA
High Flux X-ray Crystallography Data Collection System
$500,000Virginia Commonwealth University · S10 · FY2004 · RR
Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infecti
$500,000William Kwabena Ampofo · Noguchi Memorial Institute / Medical Res · U01 · FY2015 · IP
COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA
$500,000University Of Kwazulu-Natal · U19 · FY2005 · AI
Project title: RePORT Pediatrics: RePORT Prospective Observational Research for Tuberculosis in Maternal Health and Pediatrics
$500,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2016 · AI
Improving Isoniazid Preventive Therapy Penetration through Intensification of Cas
$500,000Anthony Moll · Philanjalo · U01 · FY2013 · GH
Linked: HIV-Associated Malignancies in Malawi
$500,000Johnstone Jonny Kumwenda · University Of Malawi · R24 · FY2012 · TW
VACCINE AND EVALUATION TREATMENT UNITS
$500,000Robert B. Belshe · Saint Louis University · N01 · FY2011 · AI
Targeting MDR-TB
$500,000Robert C Reynolds · Southern Research Institute · RC1 · FY2009 · AI
Ph2a Study: Rifampin, Merrem, Augmentin for Tuberculosis IND 129159; 12/31/2015
$499,999Kelly E. Dooley · Johns Hopkins University · R01 · FY2020 · FD
USE OF CATTLE MOVEMENT INFORMATION AND EPIDEMIOLOGICAL MODELING TO IMPROVE BOVINE TUBERCULOSIS RISK-BASED SURVEILLANCE
$499,999Regents Of The University Of Minnesota · · FY2013 · National Institute of Food and Agriculture
Socialization Enclosures Supporting HIV/AIDS-Related Research in SPF Macaques
$499,999Lee Hamm · Tulane University Of Louisiana · P51 · FY2024 · OD
Tulane National Primate Research Center
$499,999Lee Hamm · Tulane University Of Louisiana · P51 · FY2016 · OD
Mechanistic interrogation of the role of Type I IFN pathway in protection from SARS-CoV-2 infection in nonhuman primates
$499,999Larry S. Schlesinger · Texas Biomedical Research Institute · P51 · FY2022 · OD
Autoclave for NHP cage sterilization for the BSL3 Regional Biosafety Laboratory
$499,999Lee Hamm · Tulane University Of Louisiana · P51 · FY2019 · OD
SORP BD FACSAria II
$499,995Beth D. Jamieson-Karavodin · University Of California Los Angeles · S10 · FY2009 · RR
Tulane National Primate Research Center
$499,990Lee Hamm · Tulane University Of Louisiana · P51 · FY2023 · OD
Ph2a Study: Rifampin, Merrem, Augmentin for Tuberculosis IND 129159; 12/31/2015
$499,990Kelly E. Dooley · Johns Hopkins University · R01 · FY2017 · FD